Variants in MARC1 and HSD17B13 reduce severity of NAFLD in children, perturb phospholipid metabolism, and suppress fibrotic pathways
Christian A. Hudert, Anna Alisi, Quentin M. Anstee, Annalisa Crudele, Laura G. Draijer, EU-PNAFLD investigators, Samuel Furse, Jan G. Hengstler, Benjamin Jenkins, Kylie Karnebeek, Deirdre A. Kelly, Bart G. Koot, Albert Koulman, David Meierhofer, Stuart G. Snowden, Indra van Mourik, Anita Vreugdenhil, Susanna Wiegand, View ORCID ProfileJake P. Mann
doi: https://doi.org/10.1101/2020.06.05.20120956
